anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Nyxoah · pitchdeck

Nyxoah | IPO Presentation Deck | 34 slides

34 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Nyxoah | IPO Presentation Deck | 34 slides

Nyxoah · 2021-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 12 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits
— 0/3 slides
— 0/3 slides
33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides · 4 hits Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 17 hits
— 0/4 slides
— 0/4 slides
25% 1/4 slides 100% 4/4 slides · 5 hits
— 0/4 slides
Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Competition 3 slides 100% 3/3 slides 100% 3/3 slides · 17 hits
— 0/3 slides
66.7% 2/3 slides · 3 hits 66.7% 2/3 slides 100% 3/3 slides · 4 hits
— 0/3 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

34
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
Includes specific details on shares offered, underwriter options, insider participation, and use of proceeds.summarize
Open slide detail
04
other
Open slide detailBeat · Team
05
The slide uses a mix of bullet points and process-flow diagrams to highlight company strengths.summarize
Open slide detail
06
Uses a dual-funnel/process flow structure to contrast the total addressable market (prevalence) with the current penetration of the specific therapy (HGNS).size_opportunity
Open slide detailBeat · Market Size
07
The slide combines a Kaplan-Meier survival curve with a geographic market map and key health risk statistics.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
08
The slide uses a 'Today vs Tomorrow' framing to show product evolution.inspire_vision
Open slide detailBeat · ProblemLoop · Cost Of Inaction
09
Includes clinical definitions and references to medical literature.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
The diagram follows a non-linear path, highlighting the transition from standard CPAP therapy to the Genio System for refractory patients.present_framework
Open slide detail
11
Minimalist design with a focus on brand identity and value proposition.present_solution
Open slide detailBeat · Solution
12
The slide uses a numbered callout system to map physical components to their anatomical application site.present_solution
Open slide detailBeat · Solution
13
The slide uses visual scale references (coins) to emphasize the compact nature of the medical device components.present_solution
Open slide detailBeat · Solution
14
The slide explicitly states 'FOR ILLUSTRATIVE PURPOSES ONLY. Not a head-to-head comparison' to mitigate regulatory/legal risk.compare_peers
Open slide detailBeat · Solution
15
The slide uses a comparison table to frame the Genio system as superior to Inspire and LivaNova.compare_peers
Open slide detailBeat · Competition
16
The slide highlights Inspire's market advantage as the only FDA-approved device in the US compared to LivaNova's ongoing clinical trials.compare_peers
Open slide detailBeat · Competition
17
The slide uses a map to visualize global reach and a table to quantify patent status.present_solution
Open slide detail
18
The slide uses a process-oriented layout to map strategic goals to specific clinical trials.plan_implementation
Open slide detail
19
Clinical trial data presentation for Nyxoah's OSA treatment.analyze_data
Open slide detail
20
The map shows 5 European countries/regions with site locations.show_traction
Open slide detail
21
The slide details the methodology and status of a specific clinical trial for OSA patients with CCC.analyze_data
Open slide detail
22
The slide outlines clinical trial outcomes for a medical device, specifically focusing on AHI reduction and safety metrics.show_traction
Open slide detail
23
The slide uses a map-based visualization to show the geographic distribution of clinical trial sites.show_traction
Open slide detail
24
The slide includes a disclaimer that these are not head-to-head comparisons due to differing trial designs.show_traction
Open slide detail
25
plan_implementation
Open slide detail
26
The slide compares the company's coverage landscape against a 'Go Deep vs Go Wide' strategy for their Genio centers.plan_implementation
Open slide detail
27
The slide uses a 2x2 matrix for the 'Center of Excellence' concept and a process-oriented list for the commercialization strategy.plan_implementation
Open slide detail
28
The slide provides transparency on ownership and historical IPO data.analyze_data
Open slide detail
29
Values are in thousands of Euros. Includes a footnote regarding other operating expenses.analyze_data
Open slide detail
30
The slide presents a standard balance sheet format with footnotes explaining specific line items.analyze_data
Open slide detail
31
The chart is a floating bar chart (waterfall-style) showing cumulative allocation percentages.plan_implementation
Open slide detail
32
The slide uses a stepped timeline layout to visualize progress across funding, regulatory, and clinical milestones.show_traction
Open slide detail
33
The slide uses a dual-track timeline structure (top for EU/AU/NZ, bottom for US) converging on a shared year-based axis.plan_implementation
Open slide detail
34
state_next_steps
Open slide detail